Home > PE Ratio > COHANCE LIFESCIENCES

COHANCE LIFESCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of COHANCE LIFESCIENCES is 116.71.

Share Price ₹458.0Jun 25,2026
Market Cap ₹17,521.2 Cr
Earnings-TTM₹150.1 CrTTM-Consolidated Results
Price/Earnings116.71xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for COHANCE LIFESCIENCES
Please provide your vote to see the results
COHANCE LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of COHANCE LIFESCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of COHANCE LIFESCIENCES is calculated as :

Current Market Cap [ ₹17,521.2 Cr] as on Jun 25,2026

(/) Earnings [ ₹150.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 116.71x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for COHANCE LIFESCIENCES , the investors are currently willing to pay 116.71 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of COHANCE LIFESCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of COHANCE LIFESCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of COHANCE LIFESCIENCES


PE Ratio Performance Analysis for COHANCE LIFESCIENCES

- COHANCE LIFESCIENCES 's latest p/e ratio is 116.71x.

- COHANCE LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 53.26x.

- COHANCE LIFESCIENCES 's operated at median p/e ratio of 34.8x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, COHANCE LIFESCIENCES 's p/e ratio peaked in Mar2025 at 110.23x.

- COHANCE LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 29.26x.


How does COHANCE LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
COHANCE LIFESCIENCES 150.12116.7117,521.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5038.63446,792.0
DIVIS LABORATORIES LTD2,568.0069.37178,152.0
TORRENT PHARMACEUTICALS LTD2,138.0071.52152,915.0
CIPLA LTD3,869.7930.07116,354.0
DR REDDYS LABORATORIES LTD4,144.2027.19112,681.0
MANKIND PHARMA LTD1,926.4152.76101,632.0
LUPIN LTD5,355.4720.00107,091.0
ZYDUS LIFESCIENCES LTD5,026.4021.86109,875.0
AUROBINDO PHARMA LTD3,501.4525.5589,468.4
LAURUS LABS LTD889.8588.0778,368.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs COHANCE LIFESCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.00x
Max industry PE 116.71x
Median industry PE 38.63x
Average industry PE 51.07x



You may also like the below Video Courses